Cefea Sp. z o.o. S.K
Cefea Sp. z o.o. S.K is recorded as a service provider in 10 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 10 of 10 trials · Latest update first
Pharmacological treatment of compulsive sexual behaviour disorder
Sponsor Centrum Medycznego Ksztalcenia Podyplomowego
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of metformin effect on the fertility of women treated with 131I for thyroid cancer
Sponsor Medical University Of Bialystok
- Start (EU)
- Latest update
- Estimated end
- Not reported
Safety Outcomes Post Kidney Biopsy – randomized clinical Evaluation of Efficacy of Desmopressin
Sponsor Medical University Of Bialystok
- Start (EU)
- Latest update
- Estimated end
- Not reported
A phase 2 clinical trial assessing the efficacy and safety of adding cladribine for treatment modifying course of seropositive myasthenia gravis
Sponsor Uniwersytet Medyczny W Lublinie
- Start (EU)
- Latest update
- Estimated end
- Not reported
LAMAinDiab - lisdexamphetamine vs methylphenidate for pediatric patients with ADHD and type 1 diabetes - a randomized crossover clinical trial.
Sponsor Medical University Of Lodz
- Start (EU)
- Latest update
- Estimated end
- Not reported
A randomized, controlled, double-blind clinical trial evaluating the effect of METformin treatment on endometrial function in women diagnosed with Idiopathic Infertility
Sponsor Medical University Of Bialystok
- Start (EU)
- Latest update
- Estimated end
- Not reported
Non-commercial clinical trial of statins CAncer preventive and Pleiotropic TherApy IN smokers with chronic obstructive pulmonary disease (COPD) Clinical part: Atorvastatin effect on reduction of COPD exacerbations. Genomic part: Assessment of immunobiology of COPD related lung carcinoma and inflammatory pathways activation based on gene expression profiles of the peripheral blood leukocytes (PBLs) and peripheral blood mononuclear cells (PBMCs) from smokers with chronic obstructive pulmonary disease (COPD).
Sponsor Medical University Of Bialystok
- Start (EU)
- Latest update
- Estimated end
- Not reported
Comparison of the efficacy and safety of valaciclovir in the prevention of transmission and treatment of intrauterine infection in pregnant women with primary cytomegalovirus infection depending on the used drug dose - the first Polish non-commercial non-inferiority clinical trial.
Sponsor Instytut Matki I Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
Evaluation of frequency occurrence persistent pulmonary hypertension of newborns in group of newborns born between 32 and 42 weeks of pregnancy treated by salbutamol
Sponsor Medical University Of Warsaw
- Start (EU)
- Latest update
- Estimated end
- Not reported
Multicenter, open label study using molecularly determined targeted therapies in children 3-18 years of age with DIPG (diffuse intrinsic pontine glioma- DIPG)- DIPGen
Sponsor Instytut Pomnik Centrum Zdrowia Dziecka
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Cefea Sp. z o.o. S.K?
The 2026-10-09 snapshot links Cefea Sp. z o.o. S.K to 10 distinct CTIS trials. Recorded services include Medicinal product management, 1. repackaging of IMPs 2. storage of IMPs 3. labelling of IMPs 4. release of IMPs for clinical trial 5. Transport of IMPs 6. Disposal of IMPs, Blinding of IMPs, deliveryof investigational medicinal products, external packaging, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Cefea Sp. z o.o. S.K?
The most frequently recorded therapeutic areas are Endocrinology, Gynecology, Psychiatry, Reproductive Medicine. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Cefea Sp. z o.o. S.K conducted?
The linked trials record locations in 1 country, including Poland. These are trial locations, not confirmed office locations or countries where Cefea Sp. z o.o. S.K delivered services.
What can this page tell me about Cefea Sp. z o.o. S.K's trial experience?
Browse 10 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Cefea Sp. z o.o. S.K. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Cefea Sp. z o.o. S.K.